Empagliflozin CAS 864070-44-0

Pwodwi deskripsyon

Non pwodwi: empagliflozin CAS non: 864070-44-0

 

 

Synonyms:

(2S, 3R, 4R, 5S, 6R)-2-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy) benzyl) phenyl)-6-(hydroxymethyl) tetrahydro-2H-pyran-3, 4, 5-triol;

(1S)-1, 5-Anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydro-3-furanyloxy] benzyl} phenyl)-D-glucitol;

 

 

Chimik & pwopriyete fizik

Aparans: blan off-blan poud oswa kristalizasyon

Épreuves: ≥ 99,0%

Dansite: 1.4 g/cm3

Bouyi pwen: 664.5 ° c nan 760 mmHg

Flash pwen: 355.7 ° c

Ki ap fonn pwen: 148 ° c ~ 155 ° c

 

Empagliflozin (non komes Jardiance) se yon Dwog nan klas la gliflozin, ki apwouve pou tretman nan kalite 2 dyabet nan granmoun nan 2014. Li te devlope pa Boehringer Ingelheim ak Eli Lilly ak konpayi.

Empagliflozin se yon inibite nan glikoz a sodyom ko-transpote Porter-2 (SGLT-2), ak lakoz sik nan san an yo dwe elimine pa ren a ak elimine nan pipi.

 

 

Si ou enterese nan pwodwi nou yo oswa gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

 

Pwodwi anba patant yo ofri pou R & D objektif selman. Sepandan, responsablite final la manti selman avek achte a.

 

 

 

Baj popilè: empagliflozin cas 864070-44-0, manifaktire, founise, faktori, achte, nan Stock

• On: Dabigatran Etexilate Mesylate CAS 872728-81-9
• Pwochen: Dorzagliatin CAS 1191995-00-2